DISCOUNT-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 11:46:43 2024-06-06 EDT | ||
| 1.01 EUR | +6.32% |
|
| Current month | +15.85% | ||
| 1 month | -18.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 1.01 | +6.32% |
| 24-06-05 | 0.95 | -5.00% |
| 24-06-04 | 1 | +8.70% |
| 24-06-03 | 0.92 | +12.20% |
| 24-05-31 | 0.82 | +18.84% |
Real-time BOERSE MUENCHEN
Last update June 06, 2024 at 11:46 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC8K4E |
| ISIN | DE000HC8K4E9 |
| Date issued | 2023-08-10 |
| Strike | 300 $ |
| Maturity | 2024-06-19 (13 Days) |
| Parity | 10 : 1 |
| Emission price | 0.6 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.59 € |
|---|---|
| Lowest since issue | 0.2 € |
| Spread | 0.01 € |
| Spread % | 0.98% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.89%
- Stock Market
- Certificates
- Certificat
